Results 21 to 30 of about 263,605 (160)
INFEÇÃO CUTÂNEA E PULMONAR POR MYCOBACTERIUM AFRICANUM
Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2013 A tuberculose cutânea é uma doença incomum, constituindo 1,5% de todas as formas de tuberculose. Na doença pulmonar e cutânea, as infeções causadas por Mycobacterium africanum e Mycobacterium tuberculosis podem ser clinicamente indistinguíveis. Um rapaz
Telma Francisco +4 more
doaj +1 more source
Tuberculosis ocular: un retrato portugués de este problema raro y desafiante
Galicia Clínica, 2023 Objectives: Although threatening there is not enough awareness for ocular tuberculosis, hence we intend to study and characterize the ocular tuberculosis observed on a Portuguese specialized pulmonology diagnostic center.
Kelly Lopes +2 more
doaj +1 more source
Panorama actual en el diagnóstico de la tuberculosis cutánea [PDF]
, 2009 La tuberculosis pulmonar y cutánea está causada por Mycobacterium tuberculosis. Según datos de la Organización Mundial de la Salud (OMS) se presentan alrededor de 8 millones de casos nuevos al año.
Ocampo Candiani, Jorge +2 more
core +1 more source
Veterinary Dermatology, Volume 36, Issue 4, Page 474-484, August 2025.Background – Sporotrichosis is a chronic, mycotic infection caused by fungi of the genus Sporothrix. Zoonotic sporotrichosis occurs mainly through S. brasiliensis transmission, resulting from the organism's traumatic introduction via scratches or bites, or contact with exudate from contaminated cats.
Steffanie Amadei +6 more
wiley +1 more source
Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 6, Page 1152-1162, June 2025.ALLEGRO‐LT (NCT04006457) is an open‐label, phase 3 study investigating the long‐term safety and efficacy of ritlecitinib in patients with alopecia areata (AA). In this analysis in 449 de novo patients with AA and ≥25% scalp hair loss, ritlecitinib demonstrated clinical efficacy and had an acceptable safety profile through Month 24.
C. Tziotzios +11 more
wiley +1 more source
Considerations for defining and diagnosing generalized pustular psoriasis
Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 3, Page 487-497, March 2025.Generalized pustular psoriasis (GPP) is a rare chronic skin disease with inconsistent definitions and diagnostic criteria. It is characterized by widespread pustules and erythema, which are often accompanied by other signs and symptoms. Cases of suspected GPP may benefit from laboratory testing to assess organ function as well as genetic and ...
Vimal H. Prajapati +10 more
wiley +1 more source
Revista Peruana de Medicina Experimental y Salud Pública, 2019 La vacuna Bacillus Calmette-Guerin (BCG) que se administra a los recién nacidos de países con alta incidencia de tuberculosis puede ocasionar reacciones locales hasta infección diseminada en pacientes inmunocomprometidos.
Consuelo Apagüeño-Ruiz +4 more
doaj +1 more source
Asia‐Pacific consensus recommendations on the management of generalized pustular psoriasis
The Journal of Dermatology, Volume 51, Issue 12, Page 1579-1595, December 2024.Abstract Generalized pustular psoriasis (GPP) is a rare, chronic, heterogeneous, and potentially life‐threatening disease characterized by primary, sterile, and macroscopically visible pustules with or without systemic symptoms. There are ethnic differences in the genetic mutations associated with GPP that might affect the clinical manifestations and ...
Siew Eng Choon +19 more
wiley +1 more source
Journal of the European Academy of Dermatology and Venereology, Volume 38, Issue 8, Page 1543-1554, August 2024.Abstract Background Two phase 3 trials, POETYK PSO‐1 and PSO‐2, previously established the efficacy and overall safety of deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in plaque psoriasis. Objectives To further assess the safety of deucravacitinib over 52 weeks in the pooled population from these two trials ...
Bruce Strober +14 more
wiley +1 more source